Access to anti-retroviral drugs, male in Libya
Libya: Access to anti-retroviral drugs, male was 49.0% in 2023. ▲ Rising
Access to anti-retroviral drugs, male in Libya, 2000–2023
Source: UNAIDS estimates. Measured in %.
Analysis
In 2023, access to anti-retroviral drugs, male in Libya stood at 49.0%.
The figure is up 4.3% on the previous year and down 19.7% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Libya peaked at 77.0% in 2018 and was at its lowest, 17.0%, in 2000.
Libya ranks 119th of 141 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 24 years of available data.
Access to anti-retroviral drugs, male in Libya, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 17.0% | — |
| 2001 | 19.0% | +11.8% |
| 2002 | 22.0% | +15.8% |
| 2003 | 18.0% | -18.2% |
| 2004 | 25.0% | +38.9% |
| 2005 | 29.0% | +16.0% |
| 2006 | 32.0% | +10.3% |
| 2007 | 37.0% | +15.6% |
| 2008 | 42.0% | +13.5% |
| 2009 | 49.0% | +16.7% |
| 2010 | 53.0% | +8.2% |
| 2011 | 60.0% | +13.2% |
| 2012 | 62.0% | +3.3% |
| 2013 | 61.0% | -1.6% |
| 2014 | 64.0% | +4.9% |
| 2015 | 68.0% | +6.2% |
| 2016 | 70.0% | +2.9% |
| 2017 | 71.0% | +1.4% |
| 2018 | 77.0% | +8.5% |
| 2019 | 53.0% | -31.2% |
| 2020 | 48.0% | -9.4% |
| 2021 | 47.0% | -2.1% |
| 2022 | 47.0% | +0.0% |
| 2023 | 49.0% | +4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 29.0% | 17.0% | 49.0% | 10 |
| 2010s | 63.9% | 53.0% | 77.0% | 10 |
| 2020s | 47.8% | 47.0% | 49.0% | 4 |
Countries ranked near Libya
More gender data for Libya
- Child population (UN estimates and projections) 1,888 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.23 % change on previous year (2030)
- Age population, age 00, female, interpolated 58,243 (2025)
- Age population, age 00, male, interpolated 61,596 (2025)
- Age population, age 01, female, interpolated 59,014 (2025)
- Age population, age 01, male, interpolated 62,364 (2025)
- Age population, age 02, female, interpolated 60,166 (2025)
- Age population, age 02, male, interpolated 63,519 (2025)
- Age population, age 03, female, interpolated 61,477 (2025)
- Age population, age 03, male, interpolated 64,892 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Libya?
- Access to anti-retroviral drugs, male in Libya was 49.0% in 2023, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Libya?
- The highest recorded value was 77.0% in 2018.
- What is the lowest access to anti-retroviral drugs, male recorded in Libya?
- The lowest recorded value was 17.0% in 2000.
- How does Libya rank for access to anti-retroviral drugs, male?
- Libya ranks 119th out of 141 countries with data for 2023.
- Is access to anti-retroviral drugs, male rising or falling in Libya?
- Over the last ten years it is down 19.7%. The long-run trend across the full record is rising.
- Where does this Libya data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.